Marketing Disclosure: This content was produced in connection with a marketing arrangement with Gala GLP-1
A pragmatic alternative is to prepare smaller vials from your reconstituted stock and freeze them as single-use aliquots at 20C, minimizing repeated freeze-thaw exposure to your main vial
Changes in body composition typically become apparent after 3-6 months of consistent therapy
TRANSCEND-T2D-1 (The Lancet, June 2026): HbA1c reductions up to 2.0% and weight loss up to 16.8% in type 2 diabetes patients at 40 weeks, with no plateau observed
Extensive studies have not found increased cancer risk in people using GLP-1 medications for several years
The significant 20% reduction in major adverse cardiovascular events, along with notable decreases in heart-related deaths, heart attacks, and strokes, suggests that Ozempic could be a game-changer in improving your heart health